Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast 756: #AI #Stocks discussed: (NYSE: $GLOB) (NYSE: $ZETA)

Friday, February 10, 2023

#AIEye #Podcast 756: #AI #Stocks discussed: (NYSE: $GLOB) (NYSE: $ZETA)

#AIEye #Podcast 756: #AI #Stocks discussed: (NYSE: $GLOB) (NYSE: $ZETA)

Globant Announces Update to AI Platform GeneXus, and Zeta Introduces Beta Launch of ChatBotZeta

Global #AI in #Healthcare Market to Reach $95.65B by 2028

Vancouver, Kelowna, Delta, BC – February 10, 2023 – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence

Today’s podcast is sponsored by Fintech Company AppTech Payments Corp. (NasdaqCM:APCX).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2023/021023-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2023/artificial-intelligence/02101GLOB-ZETA.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:GLOB) (NYSE:ZETA)

Globant S.A. (NYSE:GLOB) has announced a major update to its AI-powered Low Code platform, GeneXus. Specifically, the company has combined deterministic symbolic AI with LLM (Large Language Model) technology, enabling GeneXus Next to “create and maintain unprecedented enterprise software solutions in record time.” Martin Migoya, Co-Founder and CEO of Globant, said:

"Globant has been at the forefront of the AI industry for the past decade. With GeneXus Next we continue to revolutionize our industry, making it easier for companies to build digital products and reinvent their businesses for sustained growth."

Nicolás Jodal, CEO of GeneXus, commented:

"In the past, GeneXus has utilized symbolic AI to create mission-critical systems with exceptional user experiences and quality. Now, the combination of symbolic models and foundation models like GPT-3 will further speed up and simplify the development process, enabling businesses to bring value to end-users faster than ever before.”

Zeta Global Holdings Corp. (NYSE:ZETA) has introduced the beta launch of ChatBotZeta, described as “a product that reads and synthesizes trillions of consumer signals from Zeta’s proprietary Data Cloud with generative artificial intelligence (AI) to produce conversational attributes and descriptions of individuals.” According to the press release, ChatBotZeta “is being built to enhance the ZMP’s AI models and handle several processes automatically, with the goal of producing more personalized consumer experiences that impact brand growth.” David A. Steinberg, Co-Founder, Chairman, and CEO of Zeta, explained:

"Zeta has a long history of leading the marketing technology industry with AI at the core of our platform. Integrating more disruptive generative language model technology is another step toward our vision of making sophisticated marketing simple for enterprise brands. With generative models like ChatBotZeta, the ZMP’s data discovery tools will be sharper, intent-based scoring will be enhanced, and most importantly, our customers will be further empowered to drive even greater results for their business."

Global AI in Healthcare Market to Reach $95.65B by 2028

A report published by Vantage Market Research finds that the global market for AI in Healthcare is projected to grow from $6.6 billion USD in 2021 to $95.65 billion by 2028, registering a compound annual growth rate (CAGR) of 46.1 percent in the forecast period 2022-28. The following excerpt from the report’s description outlines some key factors impacting the market’s growth:

The use of AI in healthcare is at a nascent stage, but it has the potential to revolutionize the industry. Artificial intelligence can potentially lead to $150 billion annual savings for the US economy and could help create up to 400,000 new jobs by 2035. This market is estimated at $6 billion and growing rapidly because there is an increased demand for machine learning solutions in healthcare settings. Research indicates that more than 80 percent of patients would like their physicians or other healthcare professionals to make data-driven decisions that improve their outcomes as well as enhance patient satisfaction.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Podcast sponsor:

AppTech Payments Corp. (NasdaqCM:APCX) is an innovative Fintech company whose mission is to deliver a better way for businesses to provide their customers with immersive commerce experiences. Commerse™, its all-new, patent-backed technology platform powering seamless omni-channel Commerce Experiences-as-a-Service (CXS), drives highly secure, scalable, cross-border digital banking, text-to-pay, crypto payments and merchant services altogether from a single, unified stack designed to increase operational efficiencies and growth for businesses while providing the economic convenience that their customers demand from today’s commerce experiences. For more information, visit apptechcorp.com.

About Investorideas.com - Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Disclosure: APCX is a paid featured fintech stock on Investorideas.com

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com